Clik here to view.
Trends in Asia Drug Development Market
Innovation and Harmonization on the Rise As R&D costs continue to hit new heights and domestic participation in clinical trials wane, more and more biopharmaceutical companies are seeking ways to...
View ArticleClik here to view.
Pathway to Quality Cardiovascular Imaging Trials
Cardiovascular diseases are the leading cause of death in the world and as such, the cause, prevention and treatment of all cardiovascular disease remains a very active field in the research community....
View ArticleClik here to view.
Biomarkers and Personalized Medicine: Essential Tools
The use of biomarkers is expanding across all stages in the drug development process, helping bring about new and innovative practices in the treatment of many diseases, including Alzheimer's and...
View ArticleClik here to view.
Bioclinica Medical Imaging 'Raising the Bar'
As President of Bioclinica's Medical Imaging & Biomarkers business it is my pleasure to share with you that our team has been recognized by a top biopharma company with the 2017 'Raising the Bar'...
View ArticleClik here to view.
Cardiovascular Imaging: Not Just for Cardiovascular Trials
Cardiovascular disease is the leading cause of death globally with approximately 17.3 million deaths annually. Underlying heart disease are numerous conditions such as atherosclerosis, myocardial...
View ArticleClik here to view.
Congressman Patrick Meehan Visits Bioclinica
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon officesBioclinica was honored to host Congressman Patrick Meehan representing the 7th Congressional District...
View ArticleClik here to view.
8 Essential Imaging Strategies to Revolutionize Your Clinical Study
Imaging is utilized in clinical trials across most therapeutic areas and is leveraged to monitor safety, assess efficacy, and provide primary, secondary or exploratory endpoints. The challenge imaging...
View ArticleClik here to view.
Expanding Opportunities for Drug Development in Asia
Asian biopharmaceutical companies are developing more products for the global marketOver the last decade, R&D activities, pharmaceutical market size, and the number of clinical trials in Asia has...
View ArticleClik here to view.
Alzheimer's Disease Fluid Biomarkers: Highlights from AAT-AD/PD 2018 Meeting
The Alzheimer's and Parkinson's Diseases scientific and medical community gathered at the AAT-AD/PD Focus Meeting 2018 in beautiful Torino, Italy in March to share the latest research and clinical...
View ArticleClik here to view.
Seeking Clarity in the Audit Approach
Many questions still remain several years after the July 2012 ODAC (Oncologic Drug Advisory Committee) Meeting on the "Evaluation of Radiologic Review of Progression-free Survival in Non-Hematologic...
View ArticleClik here to view.
Worldwide Business with Kathy Ireland features Bioclinica!
Catch a candid discussion with Bioclinica experts as they discuss clinical trials and ways to simplify the clinical development process in a recent episode of Worldwide Business with Kathy...
View ArticleClik here to view.
Trends in Asia Drug Development Market
Innovation and Harmonization on the Rise As R&D costs continue to hit new heights and domestic participation in clinical trials wane, more and more biopharmaceutical companies are seeking ways to...
View ArticleClik here to view.
Pathway to Quality Cardiovascular Imaging Trials
Cardiovascular diseases are the leading cause of death in the world and as such, the cause, prevention and treatment of all cardiovascular disease remains a very active field in the research community....
View ArticleClik here to view.
Biomarkers and Personalized Medicine: Essential Tools
The use of biomarkers is expanding across all stages in the drug development process, helping bring about new and innovative practices in the treatment of many diseases, including Alzheimer's and...
View ArticleClik here to view.
Bioclinica Medical Imaging 'Raising the Bar'
As President of Bioclinica's Medical Imaging & Biomarkers business it is my pleasure to share with you that our team has been recognized by a top biopharma company with the 2017 'Raising the Bar'...
View ArticleClik here to view.
Cardiovascular Imaging: Not Just for Cardiovascular Trials
Cardiovascular disease is the leading cause of death globally with approximately 17.3 million deaths annually. Underlying heart disease are numerous conditions such as atherosclerosis, myocardial...
View ArticleClik here to view.
Congressman Patrick Meehan Visits Bioclinica
Bioclinica was honored to host Congressman Patrick Meehan representing the 7th Congressional District in Pennsylvania in a visit to our Audubon, Pennsylvania offices on August 28. Congressman Meehan...
View ArticleClik here to view.
8 Essential Imaging Strategies to Revolutionize Your Clinical Study
Imaging is utilized in clinical trials across most therapeutic areas and is leveraged to monitor safety, assess efficacy, and provide primary, secondary or exploratory endpoints. The challenge imaging...
View ArticleClik here to view.
Alzheimer's Disease Fluid Biomarkers: Highlights from AAT-AD/PD 2018 Meeting
The Alzheimer's and Parkinson's Diseases scientific and medical community gathered at the AAT-AD/PD Focus Meeting in March to share the latest research and clinical advances. The event, a new joint...
View ArticleClik here to view.
How to Improve NASH Eligibility Screening and Gain Insight into the...
Co-authored by Gavin Nichols.Nonalcoholic steatohepatitis (NASH) development programs are shifting focus from targeting the clinical impacts of NASH on reversing the effects of fibrosis and cirrhosis,...
View Article